Trial | Studied treatment | Control treatment | patients | ROB | Result | NCT |
---|
|
|
RELAX-AHF, 2013 | serelaxin | placebo | | | - | NCT00520806 |
|
|
McGany, 1991 | benazepril | control | | | Negative | |
Colfer, 1992 | benazepril | placebo | | Exploratory | Negative | |
|
CMRG, 1983 | captopril | placebo | | Exploratory | - | |
packer, 1986 | captopril | enalapril | | Exploratory | - | |
Magnani, 1986 | captopril | placebo | | Exploratory | - | |
Bussmann, 1987 | captopril | placebo | | Exploratory | Negative | |
Captopril Digoxin Multicenter Research Group, 1988 | captopril | placebo | | Low risk of bias | Negative | |
Magnani, 1990 | captopril | placebo | | Exploratory | - | |
Barabino, 1991 | captopril | placebo | | Exploratory | Suggesting | |
Munich MHFT (Kleber), 1992 | captopril | placebo | | Low risk of bias | Negative | |
Cilazapril-Captopril Multi-centre Group (capt vs pbo), 1995 | captopril | placebo | | Exploratory | - | |
|
Drexler, 1989 | cilazapril | placebo | | Exploratory | Negative | |
Dosseger, 1993 | cilazapril | placebo | | Exploratory | - | |
Cilazapril-Captopril Multi-centre Group (cila vs capt), 1995 | cilazapril | captopril | | Exploratory | - | |
Cilazapril-Captopril Multi-centre Group, 1995 | cilazapril | placebo | | Exploratory | - | |
|
Sharpe, 1984 | enalapril | placebo | | | - | |
Cleland, 1985 | enalapril | placebo | | Exploratory | Negative | |
McGrath, 1985 | enalapril | placebo | | | - | |
Chrysant, 1985 | enalapril | placebo | | Low risk of bias | - | |
Enalapril CHF investigators, 1987 | enalapril | control | | | Negative | |
CONSENSUS, 1987 | enalapril | placebo | | Low risk of bias | Negative | |
Rucinska-b (enalapril), 1991 | enalapril | control | | | Negative | |
Rucinska-a (enalapril), 1991 | enalapril | control | | | Negative | |
V-HeFT II, 1991 | enalapril | hydralazine+ISDN | | Low risk of bias | - | |
SOLVD treatment, 1991 | enalapril | placebo | | Low risk of bias | Suggesting | NCT00000516 |
Dickstein, 1991 | enalapril | placebo | | Exploratory | Negative | |
SOLVD prevention, 1992 | enalapril | placebo | | Low risk of bias | - | NCT00000516 |
CASSIS (enalapril), 1995 | enalapril | placebo | | Exploratory | - | |
NETWORK (2.5 bid vs 10 bid), 1998 | enalapril | enalapril | | Low risk of bias | - | |
NETWORK (5 bid vs 10 bid), 1998 | enalapril | enalapril | | Low risk of bias | - | |
|
Brown, 1995 | fosinopril | placebo | | Exploratory | - | |
FEST (Erhardt), 1996 | fosinopril | placebo | | Exploratory | - | |
|
Rucinska-c (lisinopril), 1000 | lisinopril | control | | | Negative | |
International Study Group (Lewis), 1989 | lisinopril | placebo | | Exploratory | - | |
Zwehl, 1990 | lisinopril | control | | | Negative | |
Giles, 1990 | lisinopril | control | | | Negative | |
Gilbert, 1993 | lisinopril | placebo | | | Negative | |
ATLAS, 1999 | lisinopril | lisinopril | | Low risk of bias | - | |
|
Lechat, 1993 | perindopril | placebo | | | Negative | |
PEP CHF, 2006 | perindopril | placebo | | Low risk of bias | Negative | |
|
Riegger, 1990 | | placebo | | | Negative | |
Northridge, 1991 | | placebo | | Exploratory | Negative | |
Rieger, 1991 | | placebo | | Exploratory | Negative | |
Quinapril Heart Failure Trial Investigators, 1993 | | placebo | | Exploratory | - | |
Uprichard-a, 1994 | | control | | | Negative | |
Uprichard-b, 1994 | | control | | | Negative | |
Uprichard-c, 1994 | | control | | | Negative | |
Nussberger, 1994 | | placebo | | Exploratory | - | |
|
Swedberg, 1991 | ramipril | control | | | Negative | |
Maass-a, 1991 | ramipril | placebo | | | Negative | |
Gordon, 1991 | ramipril | placebo | | Exploratory | Suggesting | |
Maass-b, 1991 | ramipril | placebo | | Exploratory | Negative | |
Maass-c, 1991 | ramipril | placebo | | Exploratory | Negative | |
Lemarie, 1992 | ramipril | placebo | | Exploratory | Negative | |
Gundersen, 1994 | ramipril | placebo | | Exploratory | - | |
|
Hampton, 1998 | trandolapril | placebo | | Exploratory | - | |
|
|
RESOLVD association, 1999 | candesartan+ACE inhibitor | ACE inhibitor only | | Exploratory | Negative | |
RESOLVD (candesartan alone), 1999 | candesartan | enalapril | | Exploratory | Negative | |
STRETCH, 1999 | candesartan | placebo | | Exploratory | - | |
SPICE, 2000 | candesartan | placebo | | Exploratory | Negative | |
CHARM-Added, 2003 | candesartan+ACE inhibitor | ACE inhibitor only | | Low risk of bias | Negative | |
ARCH-J, 2003 | candesartan | placebo | | Low risk of bias | - | |
CHARM-Alternative, 2003 | candesartan | placebo | | Low risk of bias | Suggesting | |
Mitrovic et al., 2003 | candesartan | placebo | | Exploratory | Suggesting | |
CHARM preserved, 2003 | candesartan | placebo | | Low risk of bias | - | |
|
Tonkon et al., 2000 | irbesartan+ACE inhibitor | ACE inhibitor only | | Exploratory | - | |
I-PRESERVE (McMurray), 2008 | ibesartan | placebo | | Low risk of bias | Negative | NCT00095238 |
|
Dickstein et al., 1995 | losartan | enalapril | | Exploratory | - | |
Losartan Phase III U.S., 1995 | losartan | placebo | | Exploratory | Negative | |
Losartan phase II S, 1996 | losartan | enalapril | | Exploratory | - | |
losartan phase II US, 1996 | losartan | enalapril | | Exploratory | - | |
Losartan Phase III International, 1996 | losartan | placebo | | Exploratory | Suggesting | |
ELITE, 1997 | losartan | captopril | | Exploratory | Negative | |
Lang et al., 1997 | losartan | enalapril | | Exploratory | - | |
Hamroff et al., 1999 | losartan+ACE inhibitor | ACE inhibitor only | | Exploratory | - | |
ELITE II, 2000 | losartan | captopril | | Low risk of bias | - | |
HEAAL, 2009 | losartan 150mg | losartan 50mg | | Low risk of bias | Suggesting | NCT00090259 |
NCT00090259 ongoing | losartan | losartan | | | - | NCT00090259 |
|
REPLACE, 2001 | telmisartan | enalapril | | Exploratory | - | |
|
Mazayev et al. (vs lisinopril, 1998 | valsartan | Lisinopril | | Exploratory | - | |
Mazayev et al. (vs placebo), 1998 | valsartan | placebo | | Exploratory | - | |
V-HeFT, 1999 | valsartan+ACE inhibitor | ACE inhibitor only | | Exploratory | Negative | |
Val-HeFT, 2001 | valsartan+ACE inhibitor | ACE inhibitor only | | Low risk of bias | Suggesting | |
HEAVEN, 2002 | valsartan | enalapril | | Exploratory | - | |
VALIDD, 2007 | valsartan | no valsartan | | Exploratory | Negative | NCT00170924 |
|
|
EPAMSA, 1985 | amiodarone | no treatment | | | Suggesting | |
Hamer, 1989 | amiodarone | placebo | | | Suggesting | |
Nicklas, 1991 | amiodarone | placebo | | | Negative | |
GESICA, 1994 | amiodarone | no treatment | | | Suggesting | |
STATCHF, 1995 | amiodarone | placebo | | | Negative | |
AMIOVIRT, 2003 | amiodarone | ICD | | | Negative | |
|
ANDROMEDA, 2008 | dronedarone | placebo | | | Negative | NCT00543699 |
|
|
Barzizza (ASA), 1993 | aspirin | placebo | | Exploratory | - | |
WASH (aspirin), 2004 | aspirin | no treatment | | | Negative | |
|
WATCH (clopidogrel vs aspirin) ongoing | clopidogrel | aspirin | | | - | |
|
THE-PRINCE (Kleber), 2003 | enoxaparin | UFH | | | - | |
|
COMMANDER HF, 2018 | rivaroxaban | placebo | | | Negative | NCT01877915 |
|
Barzizza (warfarin), 1993 | warfarin | placebo | | | - | |
WASH (warfarin), 2004 | warfarin | no treatment | | | Negative | |
HELAS (warfarin vs aspirin), 2006 | warfarin | aspirin | | | - | |
HELAS (warfarin vs placebo), 2006 | warfarin | placebo | | | - | |
WATCH (warfarin vs aspirin), 2009 | warfarin | aspirin | | | Suggesting | NCT00007683 |
|
|
CIBIS, 1994 | bisoprolol | placebo | | | Suggesting | |
CIBIS II, 1999 | bisoprolol | placebo | | | Suggesting | |
CIBIS II (elderly subgroup), 1999 | Bisoprolol | placebo | | | Suggesting | |
|
Pollock, 1990 | Bucindolol | placebo | | | - | |
Woodley, 1991 | Bucindolol | placebo | | | - | |
Bristow, 1994 | Bucindolol | placebo | | | - | |
MERIT-HF (elderly subgroup), 1999 | Bucindolol | placebo | | | Suggesting | |
BEST, 2001 | bucindolol | placebo | | | Suggesting | NCT00000560 |
|
Metra, 1994 | carvedilol | placebo | | | - | |
Olsen, 1995 | carvedilol | placebo | | | - | |
Krum, 1995 | carvedilol | placebo | | | - | |
Bristow (MOCHA), 1996 | carvedilol | placebo | | | - | |
Parker, 1996 | carvedilol | placebo | | | Negative | |
Colucci, 1996 | carvedilol | placebo | | | - | |
Carvedilol U.S. Trials (elderly subgroup), 1996 | Carvedilol | placebo | | | Suggesting | |
ANZ-HeFT, 1997 | carvedilol | placebo | | | Negative | |
Cohn, 1997 | carvedilol | placebo | | | - | |
CAPRICORN, 2001 | carvedilol | placebo | | | Suggesting | |
COPERNICUS (elderly subgroup), 2001 | Carvedilol | placebo | | | Suggesting | |
COPERNICUS, 2002 | carvedilol | placebo | | | Suggesting | |
COMET, 2003 | carvedilol | metoprolol | | | Suggesting | |
CARMEN (carvedilol alone), 2004 | carvedilol | enalapril | | | Negative | |
CARMEN (carvedilol+enalapril), 2004 ongoing | carvedilol+enalapril | enalapril | | | - | |
|
Engelmeier, 1985 | metoprolol | placebo | | | - | |
MDC (Waagstein), 1993 | metoprolol | placebo | | | Negative | |
Fisher, 1994 | metoprolol | placebo | | | - | |
Eichhorn, 1994 | metoprolol | placebo | | | - | |
MERIT-HF, 1999 | metoprolol | placebo | | | Suggesting | |
RESOLVD, 2000 | metoprolol | placebo | | | - | |
BEST (elderly subgroup), 2001 | Metoprolol | placebo | | | Negative | |
|
Lechat, 1991 | Nebivolol | placebo | | | - | |
Wisenbaugh, 1993 | Nebivolol | placebo | | | Negative | |
SENIORS, 2005 | nebivolol | placebo | | | - | |
|
|
Packer, 1991 | amlodipine | control | | Exploratory | - | |
Smith, 1994 | amlodipine | control | | Exploratory | - | |
Udelson, 1996 | amlodipine | control | | Exploratory | - | |
Binkley, 1996 | amlodipine | control | | Exploratory | - | |
PRAISE, 1996 | amlodipine | placebo | | Low risk of bias | Negative | |
Ghali, 1997 | amlodipine | control | | Exploratory | - | |
PRAISE II , 2000 | Amlodipine | placebo | | Low risk of bias | Negative | |
|
DiDi, 1996 | diltiazem | placebo | | Low risk of bias | Negative | |
Liao , 1998 | Diltiazem | placebo | | Exploratory | Suggesting | |
|
Kassis, 1987 | felodipine | placebo | | Exploratory | - | |
Dunselman, 1990 | felodipine | enalapril | | Exploratory | - | |
Kassis, 1990 | felodipine | placebo | | Exploratory | - | |
De Vries, 1995 | felodipine | enalapril | | Exploratory | - | |
Littler, 1995 | Felodipine | placebo | | Exploratory | Negative | |
VHeFT III, 1997 | felodipine | placebo | | Exploratory | Negative | |
|
Van den Toren, 1996 | isradipine | placebo | | Exploratory | - | |
|
MACH 1, 2000 | mibefradil | placebo | | Low risk of bias | Suggesting | |
|
Gheorghiade, 1991 | nicardipine | control | | Exploratory | - | |
Abrams, 1993 | nicardipine | control | | Exploratory | - | |
|
Schofer, 1990 | nisoldipine | captopril | | Exploratory | - | |
Rousseau, 1994 | nisoldipine | placebo | | Exploratory | - | |
Gaudron, 1996 | Nisoldipine | placebo | | Exploratory | - | |
|
|
Strey, 2005 | atorvastatin | placebo | heart failure | | - | |
Wojnicz, 2006 | atorvastatin | control | heart failure | | Negative | |
Sola, 2006 | atorvastatin | placebo | heart failure | | Negative | |
Yamada, 2007 | atorvastatin | control | heart failure | | Negative | |
|
Laufs, 2004 | cerivastatin | placebo | heart failure | | - | |
|
CORONA, 2007 | rosuvastatin | placebo | heart failure | Low risk of bias | Negative | NCT00206310 |
Krum, 2007 | rosuvastatin | placebo | heart failure | Exploratory | Negative | |
GISSI-HF rosuvastatine, 2008 | rosuvastatin | placebo | heart failure | Low risk of bias | Negative | NCT00336336 |
|
Node, 2003 | simvastatin | placebo | heart failure | | Negative | |
Hong, 2005 | simvastatin | control | heart failure | Risk of bias | Negative | |
Landmesser, 2005 | simvastatin | ezetimibe | heart failure | | - | |
|
|
Fleg, 1982 | digoxin | placebo | | | Negative | |
Lee, 1982 | digoxin | placebo | | | Negative | |
Taggart, 1983 | digoxin | placebo | | | Negative | |
Captopril-Digoxin Multicenter Research Group (CDMRG), 1988 | digoxin | placebo | | | Suggesting | |
German and Austrian Xamoterol Study, 1988 | digoxin | placebo | | | Negative | |
Guyatt, 1988 | digoxin | placebo | | | Negative | |
DiBianco, 1989 | digoxin | placebo | | | Suggesting | |
Pugh, 1989 | digoxin | placebo | | | Negative | |
Blackwood, 1990 | digoxin | placebo | | | Negative | |
Radiance, 1993 | digoxin | placebo | | | Suggesting | |
Proved, 1993 | digoxin | placebo | | | Negative | |
DIMT, 1993 | digoxin | placebo | | | Negative | |
Digitalis Investigation Group (DIG), 1997 | digoxin | placebo | | | Suggesting | NCT00000476 |
|
|
Cheitlin, 1991 | amiloride | placebo | | Exploratory | - | |
|
EPHESUS, 2003 | eplerenone | placebo | | Low risk of bias | Suggesting | |
EMPHASIS-HF, 2010 | eplerenone | placebo | | Low risk of bias | Suggesting | NCT00232180 |
REMODEL ongoing | eplerenone | placebo | | | - | NCT00082589 |
Weir ongoing | eplerenone | placebo | | Exploratory | - | NCT00132093 |
|
Boccanelli, 1986 | furosemide | captopril | | Exploratory | Negative | |
Cowley, 1986 | furosemide | captopril | | Exploratory | - | |
|
Sievert, 1989 | hydrochlorothiazide+triamterene | digoxin | | Exploratory | - | |
Nordrehaug, 1992 | hydrochlorothiazide | benazepril | | Exploratory | Suggesting | |
|
PROTECT-1 | rolofylline | placebo | | | - | NCT00328692 |
|
Mauersberger, 1985 | spironolactone+furosemide | spironolactone+butizide | | Exploratory | - | |
Dalhstrom, 1986 | furosemide + spironolactone | prenalterol | | Exploratory | Negative | |
Han, 1994 | spironolactone+captopril | captopril | | Exploratory | - | |
Barr, 1995 | spironolactone | placebo | | Exploratory | - | |
MacFadyen, 1997 | spironolactone | placebo | | Exploratory | - | |
RALES, 1998 | spironolactone | placebo | | Risk of bias | Suggesting | |
Ramires, 2000 | spironolactone | control | | Exploratory | - | |
Bednarz, 2000 | aldactone | furosemide | | Exploratory | - | |
Farquharson, 2000 | spironolactone | placebo | | Exploratory | - | |
Yee, 2001 | spironolactone | placebo | | | - | |
Tsutamoto, 2001 | spironolactone | placebo | | Exploratory | - | |
Cicoira, 2002 | spironolactone | control | | Exploratory | - | |
Cicoira, 2004 | spironolactone | control | | | - | |
Mottram, 2004 | spironolactone | placebo | | Exploratory | - | |
Macdonald, 2004 | spironolactone | placebo | | Exploratory | - | |
Agostoni, 2005 | spironolactone | placebo | | Exploratory | - | |
PIE II ongoing | spironolactone | placebo | | | - | NCT00123955 |
Nouvel essai ongoing | spironolactone | spironolactone | | Exploratory | - | NCT00125437 |
|
|
Hambrecht et al, 1995 | Exercise training | control | | | - | |
Dubach et al, 1997 | Exercise training | control | | | - | |
Giannuzzi et al, 1997 | Exercise training | control | | | - | |
Zanelli et al, 1997 | Exercise training | control | | | - | |
Willenheimer et al, 1998 | Exercise training | control | | | - | |
Belardinelli et al, 1999 | Exercise training | control | | | - | |
Wielenga et al, 1999 | Exercise training | control | | | - | |
Kiilavuori et al, 2000 | Exercise training | control | | | - | |
McKelvie et al, 2002 | Exercise training | control | | | - | |
ExTraMATCH, 2004 | Exercise training | control | | | - | |
|
|
van Veldhuisen, 2007 | darbepoetin alfa | placebo | | Exploratory | Negative | NCT00086086 |
Ponikowski, 2007 | darbepoetin alfa | placebo | | Exploratory | Negative | NCT00117234 |
STAMINA-HeFT (Ghali), 2008 | darbepoetin alfa | placebo | | Exploratory | Negative | NCT00049985 |
Parissis, 2008 | darbepoetin alfa | placebo | | Exploratory | Negative | |
Kourea, 2008 | darbepoetin alfa | placebo | | Exploratory | Negative | |
Parissis, 2009 | darbepoetin alfa | placebo | | Exploratory | - | |
|
|
PROTECT, 2010 | rolofylline | placebo | | Low risk of bias | Negative | NCT00328692 |
|
|
AMTG, 1985 | Amrinone | placebo | | | Negative | |
|
Lardoux, 1987 | Enoximone | placebo | | | Negative | |
EMTG, 1990 | Enoximone | placebo | | | Negative | |
WESG, 1991 | Enoximone | placebo | | | Negative | |
Cowley, 1994 | Enoximone | placebo | | | Negative | |
ESG, 2000 | Enoximone | placebo | | | Negative | |
EMOTE, 2007 | enoximone | placebo | | | - | |
ESSENTIAL (I and II), 2009 | enoximone | placebo | | Low risk of bias | Negative | NCT00051285 |
EMPOWER ongoing | enoximone | placebo (on top metoprolol) | | | - | NCT00077948 |
|
REFLECT II, 1991 | Flosequinan | placebo | | | Negative | |
Cowley, 1993 | Flosequinan | placebo | | | Negative | |
FACET, 1993 | Flosequinan | placebo | | | Negative | |
REFLECT, 1993 | Flosequinan | placebo | | | Negative | |
|
PRIME II, 1997 | ibopamine | placebo | | | Negative | |
|
MMTG, 1989 | Milrinone | placebo | | | Negative | |
PROMISE, 1991 | Milrinone | placebo | | | Negative | |
|
OPC-8212 MRG, 1990 | Vesnarinone | placebo | | | Negative | |
VSG, 1993 | Vesnarinone | placebo | | | Suggesting | |
VEST, 1998 | Vesnarinone | placebo | | | Negative | |
|
|
Pre-RELAX-AHF, 2009 | serelaxin | placebo | | Exploratory | - | NCT00520806 |
|
|
ASTRONAUT, 2013 | Aliskiren | placebo | | Low risk of bias | - | NCT00894387 |
ATMOSPHERE ongoing | aliskiren | Enalapril | | Low risk of bias | - | NCT00853658 |
|
|
FIRST, 1997 | epoprostenol | standard care | | Exploratory | - | |
|
Chatterjee, 1980 | hydralazine | control | | Exploratory | - | |
Franciosa, 1982 | hydralazine | placebo | | Exploratory | - | |
Conradson , 1984 | hydralazine | placebo | | Exploratory | - | |
Magorien , 1984 | hydralazine | placebo | | Exploratory | - | |
|
VHeFT I (hydralazine ISDN), 1986 | hydralazine-ISDN | placebo | | Low risk of bias | Negative | |
|
Franciosa , 1978 | isosorbide dinitrate | placebo | | Exploratory | - | |
NICE (Lewis), 1999 | isosorbide dinitrate | placebo | | | - | |
|
CASINO | levosimendan | dobutamine | | Low risk of bias | - | |
LIDO, 2002 | levosimendan | dobutamine | | Exploratory | - | |
RUSSLAN, 2002 | levosimendan | placebo | | Exploratory | - | |
REVIVE-I, 2003 | levosimendan | placebo | | Exploratory | - | |
SURVIVE, 2007 | levosimendan | dobutamine | | Low risk of bias | Negative | NCT00348504 |
REVIVE II, 2013 | levosimendan | placebo | | Exploratory | - | NCT00048425 |
|
NSGET (comparative trial), 2000 | nesiritide | control | | Low risk of bias | - | |
NSGET (efficacy trial), 2000 | nesiritide | placebo | | Low risk of bias | Negative | |
PRECEDENT, 2002 | nesiritide | dobutamine | | Exploratory | - | NCT00270400 |
VMAC (24h), 2002 | nesiritide | nitroglycerin | | Risk of bias | Negative | NCT00083772 |
VMAC (intravenous neseritide), 2002 | nesiritide | placebo | | Low risk of bias | - | NCT00083772 |
PROACTION, 2003 | nesiritide | placebo | | Low risk of bias | Negative | |
FUSION 1, 2004 | nesiritide | standard care | | Low risk of bias | - | NCT00270361 |
BNP-CARDS, 2007 | nesiritide | placebo | | Exploratory | - | NCT00186329 |
FUSION 2, 2008 | nesiritide | placebo | | Low risk of bias | - | NCT00091520 |
ASCEND-HF, 2011 | nesiritide | placebo | | Low risk of bias | Negative | NCT00475852 |
|
|
IMPRESS, 2000 | omapatrilat | lisinopril | | | Suggesting | |
OVERTURE, 2002 | omapatrilat | enalapril | | | - | |
|
|
EVEREST Clinical Status , 2007 | tolvaptan | placebo | | | - | NCT00071331 |
EVEREST Outcome, 2007 | tolvaptan | placebo | | | - | |
Udelson, 2007 | tovalpan | placebo | | Exploratory | Suggesting | NCT00043758 |